JDRF Blog

JDRF Blog

Information on research, events, activities, and news from the T1D community across Canada. 

Subscribe to the newsletter

Early results from Sernova indicate insulin production in people with type 1 diabetes

Sernova Corp., a regenerative medicine company based in London, ON., has shown in its JDRF-funded clinical trial that its cell replacement therap...

Read More

JDRF Canada partners with CIHR in new funding opportunity to develop solutions aimed at prevention, treatment, and delivery of care for diabetes

JDRF Canada partners with CIHR in new funding opportunity to develop solutions aimed at prevention, treatment, and delivery of care for diabetes

In a new funding opportunity led by the Canadian Institutes for Health Research (CIHR), JDRF will partner with the federal agency to fund several new team grants that aim to uncover new mechanisms that control the onset and progression of diabetes and its related complications. 


The impact of your voice this National Diabetes Awareness Month

The impact of your voice this National Diabetes Awareness Month

National Diabetes Awareness Month (NDAM) has officially come to an end, and we cannot thank you enough for your overwhelming support and participation. Here are some of the great initiatives you took part on that helped make this NDAM so special.


Teen athlete with type 1 diabetes pursues dreams while raising awareness

Teen athlete with type 1 diabetes pursues dreams while raising awareness

Beth Miller is a driven athlete with an indomitable spirit and a passion for life. At 16 years old, the Calgary resident has competed nationally in skiing and is currently a competitive rower who has represented her province twice at the National Rowing Championships – all while living wi...


ViaCyte Inc. Edmonton site currently recruiting

ViaCyte Inc. Edmonton site currently recruiting

ViaCyte Inc., a privately held regenerative medicine company, is seeking residents of Alberta to participate in a promising JDRF-funded clinical trial in Edmonton. The purpose of this research is to determine the safety, tolerability and efficacy of PEC-Direct™ (also known ...


Using scaffolding technology to improve islet graft outcomes in patients with type 1 diabetes

Using scaffolding technology to improve islet graft outcomes in patients with type 1 diabetes

JDRF has supported research in beta cell replacement for more than a decade, aiming to make a stem cell-based treatment for type 1 diabetes (T1D) a reality. 


Making a difference in the lives of Canadians with type 1 diabetes

Making a difference in the lives of Canadians with type 1 diabetes

Geoff Beattie has been a devoted JDRF volunteer and active fundraiser since 2004 when his daughter was diagnosed with type 1 diabetes (T1D). Currently serving as cabinet co-chair for the In Our Lifetime Campaign for Central Canada, Geoff shares his story on how the chronic illness inspired his invol...


Dear type 1, It's been a big adjustment.

Dear type 1, It's been a big adjustment.

Type 1 diabetes became a part of Danny Miller’s family’s life just 18 months ago when his son, Cody, was diagnosed.


Excess risk of heart failure in women versus men with T1D

Excess risk of heart failure in women versus men with T1D

People living with diabetes are predisposed to several different complications given their fluctuating glucose levels, which can lead to stress on their organs. When it comes to cardiovascular problems, the extra risk conferred by having type 1 diabetes (T1D) may be greater in women than men.


Supporting the T1D community for over 20 years

Supporting the T1D community for over 20 years

Carol and Larry Hagan are strong believers in giving back to the community. As parents of two children – one of whom has a chronic illness – and JDRF supporters for more than two decades, getting involved to help make a difference has always been the Vancouver couple’s motto.


Lets turn type one into type none